Leiomyosarcoma of the Female Genital Tract: A Clinicopathological Study
The Journal of Obstetrics and Gynecology of India · 30.10.2026
DOI: 10.1007/s13224-026-02453-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Obstetrics and Gynecology of India, online erschienen am 30.10.2026. Verfasst von Adhav Kshitija und 14 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background and Objective Leiomyosarcoma (LMS) is a rare, high-grade malignant mesenchymal tumor affecting the female genital tract (FGT). This study evaluates the clinicopathological spectrum, subtypes, immunohistochemical (IHC) features, and outcomes of LMS cases diagnosed at a tertiary cancer center. Material and Methods We conducted a retrospective analysis of 68 LMS cases diagnosed between 2015 and 2020. Clinical, pathological, and follow-up data were analyzed to assess associations with disease-free survival (DFS).
Result
The uterus was the most common site (79.4%), followed by the ovary (10.3%), vagina (5.9%), cervix (2.9%), and broad ligament (1.5%). The median age was 49 years. Stage I disease was seen in 80.7% of patients, and stage IV in 14%. Histologically, 75% were spindle cell, 16.2% epithelioid and 8.8% were myxoid LMS. Coagulative tumor necrosis and severe nuclear atypia was observed in 88.2% and 92% cases, respectively. The mitotic count ranged from 1–20 per mm^2. The presence of lymphovascular invasion was found in 22% of cases, which was statistically associated with the worst DFS ( p = 0.029). SMA, desmin and h-caldesmon were positive in 92%, 82%, and 71%, respectively. The median DFS was 8.2 months. Loco-regional recurrence was observed in 36% cases. Distant metastasis was observed in 74% cases, most common organ being the lung.
Conclusion
LMS of the FGT exhibits aggressive clinical behavior with frequent recurrence and metastasis. LVI is a significant adverse prognostic factor for DFS. Histological evaluation and IHC are essential for accurate diagnosis and subtype differentiation.
Zitieren
APA
Kshitija, A., Bharat, R., Neha, M., Kedar, D., Palak, P., Nilesh, S., Seema, G., Jaya, G., Sushmita, R., Biswajit, D., Prachi, M., Supriya, C., Amita, M., Gupta, S., & Menon, S. (2026). Leiomyosarcoma of the Female Genital Tract: A Clinicopathological Study. The Journal of Obstetrics and Gynecology of India. https://doi.org/10.1007/s13224-026-02453-0
Vancouver
Kshitija A, Bharat R, Neha M, Kedar D, Palak P, Nilesh S, et al. Leiomyosarcoma of the Female Genital Tract: A Clinicopathological Study. The Journal of Obstetrics and Gynecology of India. 2026. doi:10.1007/s13224-026-02453-0
BibTeX
@article{Kshitija2026,
author = {Kshitija, Adhav and Bharat, Rekhi and Neha, Mittal and Kedar, Deodhar and Palak, Popat and Nilesh, Sable and Seema, Gulia and Jaya, Ghosh and Sushmita, Rath and Biswajit, Das and Prachi, Mittal and Supriya, Chopra and Amita, Maheshwari and Gupta, Sudeep and Menon, Santosh},
title = {Leiomyosarcoma of the Female Genital Tract: A Clinicopathological Study},
journal = {The Journal of Obstetrics and Gynecology of India},
year = {2026},
doi = {10.1007/s13224-026-02453-0}
}
EUVIMED